Diabetologia

, Volume 31, Issue 11, pp 831–835 | Cite as

Urinary excretion of 1,5-anhydro-D-glucitol accompanying glucose excretion in diabetic patients

  • Y. Akanuma
  • M. Morita
  • N. Fukuzawa
  • T. Yamanouchi
  • H. Akanuma
Originals

Summary

The urinary excretion of 1,5-anhydro-D-glucitol, a pyranoid polyol, in humans was studied. The plasma of nondiabetic human subjects contained high concentrations of this polyol (>110 μmol/l), and there was a tendency for the 24-h excretion of it to become more variable in direct proportion to its plasma concentration. In contrast, diabetic patients showed lower plasma concentrations of this polyol, and the variation in the 24-h excretion of 1,5-anhydro-D-glucitol was especially notable among the patients with an extremely low plasma concentration of the polyol. This diabetic group showed a statistically significant correlation (p<0.01), between the urinary 1,5-anhydro-D-glucitol and urinary glucose. This correlation was more markedly demonstrated during a 100-g oral glucose tolerance test: parallel changes were observed in the concentrations of 1,5-anhydro-D-glucitol and glucose in the urine collected every hour after the glucose load. These observations led to the proposal that low plasma concentration of this polyol, which is observed in diabetes mellitus, may be the result of a frequent and/or prolonged high blood glucose concentration beyond the renal threshold for glucose excretion.

Key words

1,5-anhydroglucitol urinary excretion reabsorption glucosuria hyperglycaemia 

References

  1. 1.
    Pitkänen E (1973) Occurrence of 1,5-anhydroglucitol in human cerebrospinal fluid. Clin Chim Acta 48: 159–166Google Scholar
  2. 2.
    Servo C, Pitkänen E (1975) Variation in polyol levels in cerebrospinal fluid and serum in diabetic patients. Diabetologia 11: 575–580Google Scholar
  3. 3.
    Servo C, Palo J, Pitkänen E (1977) Polyols in the cerebrospinal fluid and plasma of neurological, diabetic and uremic patients. Acta Neural Scand 56: 111–116Google Scholar
  4. 4.
    Akanuma H, Ogawa K, Lee Y, Akanuma Y (1981) Reduced levels of 1,5-anhydroglucitol in diabetic patients. J Biochem 90: 157–162Google Scholar
  5. 5.
    Pitkänen E (1982) Serum 1,5-anhydroglucitol in normal subjects and in patients with insulin-dependent diabetes mellitus. Scand J Clin Lab Invest 42: 445–448Google Scholar
  6. 6.
    Yoshioka S, Fujisawa T, Fujimori A, Takatani O, Funabashi M (1982) Identification and metabolic implication of 1-deoxyglucose (1,5-anhydroglucitol) in human plasma. Clin Chem 28: 1283–1286Google Scholar
  7. 7.
    Yoshioka S, Saitoh S, Negishi C, Fujisawa T, Fujimori A, Takatani O, Imura M, Funabashi M (1983) Variation of 1-deoxyglucose (1,5-anhydroglucitol) content in plasma from patients with insulin-dependent diabetes mellitus. Clin Chem 29: 1396–1398Google Scholar
  8. 8.
    Pitkänen E, Pitkänen O (1984) The elimination of 1,5-anhydroglucitol administered to rats. Experientia 40: 463–465Google Scholar
  9. 9.
    Yamanouchi T, Akanuma H, Takaku F, Akanuma Y (1986) Marked depletion of plasma 1,5-anhydroglucitol, a major polyol, in streptozocin-induced diabetes in rats and the effect of insulin treatment. Diabetes 35: 204–209Google Scholar
  10. 10.
    Yamanouchi T, Akanuma H, Nakamura T, Akaoka I, Akanuma Y (1988) Specific reduction of plasma 1,5-anhydroglucitol (1-deoxyglucose) concentration in diabetic patients. Diabetologia 31: 41–45Google Scholar
  11. 11.
    Yamanouchi T, Akanuma H, Asano T, Konishi C, Akaoka I, Akanuma Y (1987) Reduction and recovery of plasma 1,5-anhydro-D-glucitol in diabetes mellitus. Diabetes 36: 709–715Google Scholar
  12. 12.
    Kametani S, Hashimoto Y, Yamanouchi T, Akanuma Y, Akanuma H (1987) Reduced renal reabsorption of 1,5-anhydro-D-glucitol in diabetic rats and mice. J Biochem 102: 1599–1607Google Scholar
  13. 13.
    WHO study group (1985) In “Diabetes Mellitus” (Technical report series 727). World Health Organization, GenevaGoogle Scholar
  14. 14.
    Ohkubo A, Kamei S, Yamanaka M, Arai F, Kitajima M, Kondo A (1981) Plasma glucose concentrations of whole blood, as determined with a multilayer-film analytical element. Clin Chem 27: 1287–1290Google Scholar
  15. 15.
    Crane RT, Mandelstam P (1960) The active transport of sugars by various preparations of hamster intestine. Biochim Biophys Acta 45: 430–475Google Scholar

Copyright information

© Springer-Verlag 1988

Authors and Affiliations

  • Y. Akanuma
    • 1
  • M. Morita
    • 2
  • N. Fukuzawa
    • 1
  • T. Yamanouchi
    • 3
  • H. Akanuma
    • 2
  1. 1.Institute for Diabetes Care and ResearchAsahi Life FoundationJapan
  2. 2.Department of Chemistry, College of Arts and SciencesUniversity of TokyoJapan
  3. 3.The Second Department of Internal MedicineUniversity of TeikyoTokyoJapan

Personalised recommendations